These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18700551)

  • 1. [Pathophysiology of mild hypertension: role of endothelial function].
    Matsuoka H; Imaizumi T
    Nihon Rinsho; 2008 Aug; 66(8):1517-24. PubMed ID: 18700551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial factors and microvascular hypertensive disease.
    Rizzoni D; Agabiti-Rosei E
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S15-8. PubMed ID: 11811369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [NO and hypertension].
    Hirata Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():243-6. PubMed ID: 15171377
    [No Abstract]   [Full Text] [Related]  

  • 5. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
    Ong HT; Rozina G
    Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of elderly hypertension].
    Rakugi H
    Nihon Jinzo Gakkai Shi; 2009; 51(4):471-5. PubMed ID: 19601556
    [No Abstract]   [Full Text] [Related]  

  • 7. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies].
    Katayama S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Curr Hypertens Rep; 2000 Feb; 2(1):64-70. PubMed ID: 10981130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin-Converting Enzyme Inhibitors-Beneficial Effects Seen in Many Patient Groups May Not Extend to Kidney Transplant Recipients.
    Cross NB; Webster AC
    Transplantation; 2016 Mar; 100(3):472-3. PubMed ID: 26900806
    [No Abstract]   [Full Text] [Related]  

  • 14. [Principal entity of hypertension version of CKD guide].
    Kimura G
    Nihon Jinzo Gakkai Shi; 2009; 51(4):442-5. PubMed ID: 19601550
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y; Jacob RF; Mason RP
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intervention trials for elderly hypertension in Western countries].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2005 Jun; 63(6):1071-7. PubMed ID: 15948393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive treatment on endothelial function.
    Virdis A; Ghiadoni L; Taddei S
    Curr Hypertens Rep; 2011 Aug; 13(4):276-81. PubMed ID: 21499710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The L-arginine-nitric oxide pathway in hypertension.
    Kelm M
    Curr Hypertens Rep; 2003 Feb; 5(1):80-6. PubMed ID: 12530940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
    Yoshida D; Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():533-7. PubMed ID: 15779436
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium channel blockers or angiotensin-converting enzyme inhibitors for de novo hypertension after liver transplant: and the winner is …?
    Carbone M; Sagar V; Ferguson J; Neuberger J
    Transplantation; 2012 Jan; 93(2):e2-4. PubMed ID: 22234315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.